US3043747A - Tablets coated with carboxymethylcellulose shellac composition - Google Patents

Tablets coated with carboxymethylcellulose shellac composition Download PDF

Info

Publication number
US3043747A
US3043747A US90223A US9022361A US3043747A US 3043747 A US3043747 A US 3043747A US 90223 A US90223 A US 90223A US 9022361 A US9022361 A US 9022361A US 3043747 A US3043747 A US 3043747A
Authority
US
United States
Prior art keywords
coating
shellac
composition
ingredients
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US90223A
Inventor
Long Stuart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Priority to US90223A priority Critical patent/US3043747A/en
Application granted granted Critical
Publication of US3043747A publication Critical patent/US3043747A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats

Definitions

  • the coating of medicinal tablets for oral use is an old and often practiced process of the pharmaceutical art. Many advantages are obtained by a coating such as protection from chipping or breaking during handling and protection from the atmosphere during storage. Other advantagesfrom the standpoint of the person who must take the medicament, are a pleasing appearance, masking of disagreeable taste or odor and ease of swallowing.
  • composition is compatible with the addition of one or more or any combination of the following types of coating adjuvants: coloring agents, opacifiers, plasticizers, flavoring agents, and sweetening agents. Also, dusting materials can be applied between applications of the composition in the coating process and waxes applied to polish the coating.
  • the present invention permits flexibility in th: e; tration of the various ingredients.
  • the preferred concentrations given represent the range wherein the maximum advantage of the invention is obtained. Outside the preferred concentration the advantages are obtained, although to a lesser degree, and diminish as the concentration is varied away from the preferred range.
  • a low viscosity form of the cellulose derivative is preferred as the solutions with higher solids content permit the formation of a coating in a lesser number of applications than is needed by solutions containing a low solids content. For example, one application of 200 cc. of a 10% solution would be equivalent, in terms of coating deposited, to 5 applications (1000 cc.) of a 2% solution.
  • An opacifier such as titanium dioxide
  • titanium dioxide can be added to the composition with advantage in a concentration of about 1%.
  • the coating will be opaque enough so as not to warrant the addition of an opacifier.
  • compositions of the present invention are not to be construed as limiting.
  • Example 4 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
  • Ethanol 350 Methylcellulose, 400 cps 40 Polyethylene glycol 400, 20 Shellac, arsenic-free, 30% w./w. in ethanol 87 Deionized water 500 Oil of Wintergreen 2 RD. and C. Red No. l l
  • Example 8 Gms. Ethanol 250 Methylcellulose, 15 cps 100 Shellac, arsenic-free, 30% w./w. in ethanol 150 Deionized water 500 The ingredients are mixed together in the above order with oontinuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
  • Example 12 One thousand grams of the composition of the present 7 invention are prepared from the following types and amounts of ingredients:
  • Example 14 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
  • the ingredients are mixed together in the above order with continuous stirring.
  • the mixture is stirred for at least 30 minutes after the addition of the last ingredient.
  • the most common method of application is the ladle technique whereby the coating composition is applied by pouring small quantities of coating material onto the tablets as they are tumbling in a coating pan. Each application of coating material is made in an amount sufficient to cover each tablet with a thin film of mate rial. A dusting powder can be applied, if desired, after each application and a current of warm air blown over the tablets to dry them.
  • As few as 5 or as many as 25 applications of coating material will form a satisfactory tablet coat with applications being preferred.
  • a solid medicinal dosage form having thereon a i 5.
  • a coated tablet wherein the coating comprises intermixed shellac and a water soluble cellulose derivative selected from the group consisting of methylcellulose, hy droxyethyl cellulose and sodium carboxymethylcellulose in the proportion of 100 parts by weight of said cellulose member to from about 40 parts to about 100 parts by weight of said shellac.
  • a solid medicinal dosage form having thereon a dry coating comprising intermixed methylcellulose and shellac.

Description

United States Patent 3,043,747 TABLETS COATED WITH CARBOXYMETHYLCEL- LUDOSE SHELLAC COMPOSITION Stuart Long, Kalamazoo, Mich asslgnor to 'Ihe U john Company, Kalamazoo, Mich a corporation of elawere No Drawing. Continuation of application: Ser. No. 768,852, Oct. 22, 1958, now Patent No. 2,997,784, dated Aug. 29, 1961, Ser- No. 768,854, and Ser. No. 768,855, Oct. 22, 1958. This application Feb. 20, 1961, Ser. No. 90,223
20 Claims- (Cl. 167-82) This invention relates to an improved coating for solid medicinal dosage forms, and more particularly to an improved coating composition of a water-soluble cellulose derivative and solid medicinal dosage forms which have been coated therewith.
This application is a continuation of applications Serial No. 768,552, now U.S. Patent 2,997,784; 768,854; and 768,855; all filed on even date of October 22, 1958.
The coating of medicinal tablets for oral use is an old and often practiced process of the pharmaceutical art. Many advantages are obtained by a coating such as protection from chipping or breaking during handling and protection from the atmosphere during storage. Other advantagesfrom the standpoint of the person who must take the medicament, are a pleasing appearance, masking of disagreeable taste or odor and ease of swallowing.
Many coating materials have been used, with coatings consisting essentially of sugar being the most popular. The use of sugar coatings requires a time consuming multiplicity of steps in the process of application.
In recent years a new group of materials has been made available and is finding acceptance and use in the coating art. This group consists of cellulose derivatives, cg, methylcellulose, sodium carboxymethylcellulose, hydroxyethyl cellulose, ethyl cellulose, cellulose acetate phthalate, and others, and forms what is called a film coating. The members of this group are of two types, the water soluble and water insoluble.
For coatings that are to disintegrate and release the medicament in the stomach, the water soluble types are preferred. The coating procedures used in the past have consisted of the following sequence of steps: first, the application of a sealing coat of shellac and then the coating solution containing a particular cellulose derivative is applied. A characteristic inherent in these compositions and their use is the tendency for the cellulose derivative to be deposited over the surface in a film of uneven thickness, leaving the edges with a lesser amount of covering material. Another characteristic of the coating is that, with the passage of time or on ageing, the disintegration time increases and the medication is not released as quickly. Both of the preceding characteristics are disadvantages for a coating which is intended to disintegrate in the stomach.
It is therefore an object of the present invention to provide a composition suitable for the coating of solid medicinal dosage forms. Another object is to provide a coating composition which will adhere and form a coating of uniform thickness when applied by the usual methods. Still another object is to provide a coating composition which forms a coating that will rapidly disintegrate in the stomach and which will not materially lengthen its disintegration time on ageing. A further object is to provide a solid medicinal dosage form with such a coating material. A still further object is to provide a solid medicinal dosage form wtih a coating which is uniform in thickness. A still further object is to provide a solid medicinal dosage form with a coating which allows rapid disintegration and release of medicament in the stomach 3,043,747 Patented July 10, 1962 unafiected by ageing. Others objects will be apparent to one skilled in the art to which this invention pertains.
'Ihe foregoing and additional objects have been accomplished by the provision of a composition for coating solid medicinal dosage forms comprising a hydro-alcoholic solution containing dissolved therein a member selected from the group of water-soluble cellulose derivatives consisting of methylcellulose, hydroxyethyl cellulose and sodium carboxymethylcellulose and suspended particles of purified, arsenic-free shellac. According to this invention it has been discovered that the presence of shellac particles suspended in a hydro-alcoholic solution of cellulose derivative form an improved coating composition for solid medicinal dosage forms, especially tablets. When the composition is applied to the surface of a tablet, the shellac apparently has the ability to keep the cellulose derivative from slipping upon evaporation of the solvent and thereby leaves the tablet edges covered with the same thickness of coating as the rest of the coating. The composition when applied by the usual methods forms a coating of uniform thickness. Because of such adherence to the edges, and even deposition of material, fewer applications and a lesser amount of coating composition is required, resulting in the following advantages: a solid medicinal dosage form which is smaller than that coated by other means with attendant savings in material, packing and shipping costs, and ease of swallowing; a savings of time and labor; a coating that will rapidly grate. The application of shellac and cellulose derivative as a single composition results in a coating which can rapidly disintegrate in the stomach, even after ageing. Furthermore, the composition is compatible with the addition of one or more or any combination of the following types of coating adjuvants: coloring agents, opacifiers, plasticizers, flavoring agents, and sweetening agents. Also, dusting materials can be applied between applications of the composition in the coating process and waxes applied to polish the coating.
An unexpected advantage of the compositions of the present invention is the ability to provide coatings which can be readily polished to an elegant lustre by conventional means.
Additional advantages furnished by a coating obtained from the composition of the present invention are protection from atmospheric moisture, covering any disagreeable taste or odor, and protection from chipping or breaking during handling. The coating also provides a suitable base for further applications of other material, such as other medicaments or other types of coating material.
The present invention finds its principal use in the coating of medicinal tablets and is particularly advantageous for coating irregularly shaped tablets, i.e., whose shape is other than the usual round type, having an increased number of edges. However, other medicinal forms can be coated and for this reason the term "solid medicinal dosage forms is used. The term "solid medicinal dosage form is used in the generic sense to mean those objects with a shaped form that are intended to serve as a carrier. for a dosage unit of medication. For example, the term would include such pharmaceutical forms as tablets, pills, pillules, wafers, and granules.
The present invention permits flexibility in th: e; tration of the various ingredients. The preferred concentrations given represent the range wherein the maximum advantage of the invention is obtained. Outside the preferred concentration the advantages are obtained, although to a lesser degree, and diminish as the concentration is varied away from the preferred range.
Each of the water-soluble cellulose derivatives, e.g., methylcellulose, hydroxyethyl cellulose and sodium carboxymethylcellulose are available in a variety of forms disinte which difier in the degree of viscosity imparted to aqueous solutions of identical concentration. The forms may be described as being low viscosity (less than 100 cps.), medium viscosity, and high viscosity (greater than 1500 cps.). Satisfactory coating compositions can be prepared using any of the various forms in a concentration, dependent upon the particular form used, of from about 2% to about 10%. For example, it is possible to prepare solutions with higher solids content from the low viscosity forms than from the high viscosity forms and still maintain the required fluidity for coating purposes. The preferred concentrations for the various forms are: low viscosity methylcellulose, from about to about medium viscosity methylccllulose, from about 3 to about 5%; high viscosity methylcellulose, from about 2 to about 3%. Mixtures of the several forms can be used and the concentration would then depend upon the particular forms and their proportional relationship.
A low viscosity form of the cellulose derivative is preferred as the solutions with higher solids content permit the formation of a coating in a lesser number of applications than is needed by solutions containing a low solids content. For example, one application of 200 cc. of a 10% solution would be equivalent, in terms of coating deposited, to 5 applications (1000 cc.) of a 2% solution.
Expressed in general terms, the maximum concentration of the cellulose derivative is that amount (a) which will dissolve in the hydro-alcoholic solvent and (b) which when dissolved will form a solution that is of such viscosity as to have the fluidity necessary for application. Whether (a) or (b) limits the maximum concentration is dependent upon the alcohol-water proportions. For example, with a high alcohol and low water relationship, the maximum concentration would depend upon solubility of (a). Conversely, with a low alcohol and high water relationship the concentration would depend upon viscosity or (b).
The minimum concentration of the cellulose derivative can be very low; however, practical considerations require a concentration which will furnish suflicient cellulose derivative to deposit a coating in a reasonable number of applications.
The shellac used in the composition of the present invention is the refined, arsenic-free grade which is non-toxic and suitable for medicinal purposes. This type of shellac is also known as confectioners glaze. The shellac can be used in the dry flake form; however, it is more convenient to use the commercially available solution of shellac, 30% w./w. in ethyl alcohol. The amount of shellac to be present in the composition is dependent upon the amount of cellulose derivative present and is expressed in terms of percent by weight of the cellulose. The preferred concentration is from about 40 to about 100% by weight of the cellulose.
Coating compositions can be prepared using a greater or lesser concentration than that given as the preferred; however, disadvantages occur as a result of such variation. For example, a lesser concentration results in a loss of the advantages of an even deposition of cellulose, with such loss being gradual and in proportion to the decreasing concentration of shellac. An increase in concentration results in disadvantages which are observable as characteristics of the composition's stability and the finished coat. The stability of the composition is altered by increasing the shellac concentration for reason of increased solid particles and the tendency of the particles to conglomerate and settle out of the composition as an amorphous mass which cannot be resuspended, thereby ruining the composition for coating purposes. Increasing the shellac concentration of the composition results in an increased shellac concentration in the coating; the coating takes on the characteristics of a shellac coating and loses the characteristics of a cellulose coating and results in an increase in disintegration time on ageing.
' hols which can be used are those which dissolve the shellac and when mixed with water will precipitate the shellac in very fine particles.
A preferred adjuvant for the coating composition is a plasticizer, such as propylene glycol, glycerin, or polyethylene glycol (200-600), and is added in an amount of about 1 to 3 grns. per gms. of composition. Plasticizers, such as propylene glycol and glycerin, which are soluble in the hydro-alcoholic media are preferred to those non-soluble plasticizers such as cottonseed oil and corn oil, which have a tendency to separate from the composition.
Coloring agents can be added to the coating compositions when a colored coating is desired. The coloring agents which can be used are any of the non-toxic dyes, lakes, or pigments which have been certified for use in the food, drug, and cosmetic industry. For example, ED. and C. Blue No. 1, PD. and C. Yellow No. 1, ED. and C. Yellow No. 5, RD. and C. Orange No. l, D. and C. Orange No. 1, D. and C. Green No. l and others. The coloring agents, singly or in combination, are added in an amount of about 1 gm. to 1000 gms. of coating composition.
Flavoring and sweetening agents can be added to impart a pleasant taste to the coating. A few examples of suitable agents and the preferred concentrations are: peppermint oil, 0.4%; oil of Wintergreen, 0.2%; anise oil, 0.15%; lemon extract, 0.5%; licorice, 0.5%; imitation cherry, 0.5% sodium saccharin, 0.2%; and sodium cyclamate, 0.6%.
An opacifier, such as titanium dioxide, can be added to the composition with advantage in a concentration of about 1%. In certain cases, depending on the color of the coating composition and/or the dusting powder used, the coating will be opaque enough so as not to warrant the addition of an opacifier.
The compositions are prepared by wetting the cellulose derivative with part of the alcohol, dissolving the shellac in the remaining alcohol (that is, unless the commercial shellac dissolved in alcohol is used), mixing the two together, and then adding the water and stirring. When additional ingredients are added such as color and flavor, they are added after the water and stirred until well disperscd.
Although the order of mixing is not critical, it is more convenient to follow the before-mentioned procedure. For example, if the cellulose derivative is added to the water without first wetting with alcohol, the length of time required to dissolve the cellulose is considerably extended. Also it is more diflicult to dissolve the cellulose if it is wctted with alcohol containing shellac.
The following examples are illustrative of the compositions of the present invention and are not to be construed as limiting.
Example 1 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 2 One thousand grams of the composition are prepared from the following types and amounts of ingredients:
Gina. Ethanol 314 Methylcellulose, 25 cps 60 Glycerin 25 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 FD. and C. Yellow No. 1
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 3 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms. Ethanol 330 Methylcellulose, 25 cps 70 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 4 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms.
Ethanol 350 Methylcellulose, 400 cps 40 Polyethylene glycol 400, 20 Shellac, arsenic-free, 30% w./w. in ethanol 87 Deionized water 500 Oil of Wintergreen 2 RD. and C. Red No. l l
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 5 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms.
Methanol 439 Methylcellulose, 1500 cps 20 Propylene glycol l0 Shellac, arsenic-free 20 Color i 1 Titanium oxide l0 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 6 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms. Ethanol 320 Methylcellulose, 25 cps 50 Glycerin 25 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 Sodium saccharin 2 Oil of Wintergreen 2 PD. and C. Red No. l l
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 7 One thousand grams ,of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms.
Ethanol 350 Methylcellulose, 25 cps 50 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at. least 30 minutes after the addition of the last ingredient.
Example 8 Gms. Ethanol 250 Methylcellulose, 15 cps 100 Shellac, arsenic-free, 30% w./w. in ethanol 150 Deionized water 500 The ingredients are mixed together in the above order with oontinuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 9 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms. Ethanol 340 Hydroxyethyl cellulose, 25 cps $0 Propylene glycol l0 Shellac, arsenic-free, 30% w./w. methanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
The ingredients are mixed together in the above order with continuous stirring. The mixture is'stirred for at least 30 minutes after the addition of the last ingredient.
Example 11 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms.
Ethanol 330 Hydroxyethyl cellulose, 25 cps Shellac, arsenic-free, 30% w./w. in ethanol Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 12 One thousand grams of the composition of the present 7 invention are prepared from the following types and amounts of ingredients:
Grams Ethanol 350 Hydroxyethyl cellulose, 400 cps 40 Polyethylene glycol 400 20 Shellac, arsenic-free, 30% w./w. in ethanol 87 Deionized water 500 Oil of Wintergreen 2 RD. and C. Red No. l l
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 13 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Grams Methanol 439 Hydroxyethyl cellulose, 1500 cps 20 Propylene gly Shellac, arsenic-free 20 Color 1 Titanium oxide 10 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 14 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 15 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Grams Ethanol 350 Hydroxyethyl cellulose, 25 cps 50 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 16 Grams Ethanol 250 Hydroxyethyl cellulose, 15 cps 100 Shellac, arsenic-free, 30% wJw. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 17 One thousand grams of the composition of the present 8 invention are prepared from the following types and amounts of ingredients:
Grams Ethanol 350 Sodium carboxymethylcellulose, 25 cps 50 Propylene gly 10 Shellac, arsenic-free, 30% wJw. in ethanol Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 18 One thousand grams of the composition are prepared from the following types and amounts of ingredients:
Grams Ethanol 314 Sodium carboxymethylcellulose, 25 cps 60 Glycerin 25 Shellac, arsenic-tree, 30% wJw. in ethanol 100 Deionized water 500 F.D. and C. Yellow No. 5 1
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 19 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Grams Ethanol 330 Sodium carboxymethylcellulose, 25 cps 70 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 20 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Grams Ethanol 350 Sodium carboxymethyloellulose, 400 cps 40 Polyethylene glycol 400 20 Shellac, arsenic-free, 30% 'wJw. in ethanol 87 Deionized water 500 Oil of Wintergreen 2 ED. and C. Red No. 1 l
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 21 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Grams Methanol 439 Sodium carhoxymethylcellulose,l500 cps 20 Propylene gly 10 Shellac, arsenic-free 20 Color 1 Titanium oxide 10 Deioniaed water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition or the last ingredient.
Example 22 One thousand grams of the composition of the present invention are prepared from the following types an amounts of ingredients:
Gms. Ethanol 320 Sodium carboxymethylcellulose, 25 cps 5O Glycerin 25 Shellac, arsenic-free, 30% w/w. in ethanol 100 Deionized water Sodium saccharin 2 Oil of winte'rgreen 2 PD. and C. Red No. l l
The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 23 One thousand grams of the composition of the present invention are prepared from the following types and amounts of ingredients:
Gms. Ethanol 350 Sodium carboxymethylcellulose, 2S cps S0 Shellac, arsenic-free, 30% w./w. in ethanol 100 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
Example 24 Gms. Ethanol 250 Sodium carboxymethylcellulose, 15 cps lOO Shellac, arsenic-tree, 30% w./w. in ethanol 150 Deionized water 500 The ingredients are mixed together in the above order with continuous stirring. The mixture is stirred for at least 30 minutes after the addition of the last ingredient.
The coating compositions of the present invention, as illustrated by the preceding examples, can be applied by the usual coating procedures using conventional coating equipment to provide the various advantages of the invention as indicated previously.
The most common method of application is the ladle technique whereby the coating composition is applied by pouring small quantities of coating material onto the tablets as they are tumbling in a coating pan. Each application of coating material is made in an amount sufficient to cover each tablet with a thin film of mate rial. A dusting powder can be applied, if desired, after each application and a current of warm air blown over the tablets to dry them. When using the compositions of the present invention, as few as 5 or as many as 25 applications of coating material will form a satisfactory tablet coat with applications being preferred.
Any of the dusting materials common in the art can be used, such as talc, calcium sulfate, and calcium carbonate. A preferred dusting composition is one comprised of calcium sulfate 95% and powder acacia 5%. This preferred composition is not only an excellent dusting material but, also is a good opacifier.
The coating can be polished by conventional means using such agents as beeswax, stearic acid, onesta wax, carnauba wax, cetyl alcohol, and others. A preferred waxing composition is comprised of carnauba wax, chlorowax, and mineral oil dissolved in tetracblorethylene.
Example 25 Ten thousand average size (as inch punch) tablets are placed in an 18-inch coating pan and the pan allowed to rotate at about 30 revolutions per minute. About 2 fluid ounces of the coating solution of Example I are ladled over the tablets. The tablets are allowed to roll until covered with the composition and they have become tacky, and are then dusted with coating powder. When the coating powder has been taken up by the tablets, a current of warm air is blown over the tablets until dry. The procedure is repeated until it) applications of coating material have been applied. The tenth application of coating material is not followed by an application of dusting material. The tablets are dried at 110 F. overnight and then polished by rolling in canvas-lined tubs with the application of 2 fluid ounces of polishing composition.
Following the procedure of Example 25, tablets can also be coated using one of the coating compositions shown by Examples 2-24 in place of the composition of Example 1.
What is claimed is:
1. A solid medicinal dosage form coating composition for applying an even and uniform film coating which does not appreciably lengthen in disintegration time on ageing comprising a hydroalcoholic solution of a water soluble cellulose derivative selected from the group consisting of methylcellulose, hydroxyethyl cellulose and sodium carbo'xymethylcellulosc and suspended shellac.
2. A composition of matter comprising a hydroalcoholic solution of a water soluble cellulose derivative selected from the group consisting of methylcellulose,
hydroxyethyl cellulose and sodium carboxymethylcellulose and suspended shellac, said cellulose derivative being present in a concentration of from about 2 to about 10% (w./w.) of said composition and said shellac being present in a concentration of from about 40% to about by weight of said cellulose derivative.
3. A solid medicinal dosage form having thereon a i 5. A coated tablet wherein the coating comprises intermixed shellac and a water soluble cellulose derivative selected from the group consisting of methylcellulose, hy droxyethyl cellulose and sodium carboxymethylcellulose in the proportion of 100 parts by weight of said cellulose member to from about 40 parts to about 100 parts by weight of said shellac.
6. A solid medicinal dosage form coating composition for applying an even and uniform film coating which does not appreciably lengthen in disintegration time on ageing comprising a hydro-alcoholic solution of methylcellulose and suspended shellac.
7. A composition of matter comprising a hydro-alcoholic solution of methylcellulose and suspended shellac, said methylcellulose being present in a concentration of from about 2 to about 10% (w./w.) of said composition and said shellac being present in a concentration of from about 40% to about l00% by weight of said methylcellulose.
8. A solid medicinal dosage form having thereon a coating comprising intermixed methylcellulose and shellac.
9. A solid medicinal dosage form having thereon a dry coating comprising intermixed methylcellulose and shellac.
ID. A coated tablet wherein the coating comprises intermixed methylcellulose and shellac in the proportio of 100 parts by weight of methylcellulose to from about 40 parts to about 100 parts by weight of shellac.
ll. A solid medicinal dosage form coating composition for applying an even and uniform film coating which does not appreciably lengthen in disintegration time on ageing comprising a hydro-alcoholic solution of hydroxyethyl cellulose and suspended shellac.
l2. A composition of matter comprising a hydro'alcoholic solution of hydroxyethyl cellulose and suspended 1 l shellac, said hydroxyethyl cellulose being present in a concentration of from about 2 to about (w./w.) of said composition and said shellac being present in a concentration of from about 40% to about 100% by weight of said hydroxyethyl cellulose.
13. A solid medicinal dosage form having thereon a coating comprising intermixed hydroxyethyl cellulose and shellac.
14. A solid medicinal dosage form having thereon a dry coating comprising intermixed hydroxyethyl cellulose and shellac.
IS. A coated tablet wherein the coating comprises intermixed hydroxyethyl cellulose and shellac in the proportion of 100 parts by weight of hydroxyethyl cellulose to from about 40 parts to about 100 parts by weight of shellac.
16. A solid medicinal dosage form coating composition for applying an even and uniform film coating which does not appreciably lengthen in disintegration time on ageing comprising a hydro-alcoholic solution of sodium earboxyrnethylcellulose and suspended shellac.
17. A composition of matter comprising a hydro-alcoholic solution of sodium carboxymethylcellulose and susended shellac, said sodium carboxymethylcellulose being present in a concentration of from about 2 to about 10% (w./w.) of said composition and said shellac being present in a concentration of from about to about l00% by weight of said sodium carboxymethylcellulose.
18. A solid medicinal dosage form having thereon a coating comprising intermixed sodium carboxymethylcellulose and shellac.
19. A solid medicinal dosage form having thereon a dry coating comprising intermixed sodium carboxymethylcellulose and shellac.
20. A coated tablet wherein the coating comprises intermixed sodium carboxymethylcellulosc and shellac in the proportion of parts by weight of sodium carboxymethylccllulose to from about 40 parts to about 100 parts by weight of shellac.
No references cited.
UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Pa Lent No. 3,043, 747
July 10, 1962 Stuart Long It is hereby certified that ent requiring correction and that corrected below.
error appears in the above numbered patthe said Letters Patent should read as Column l line 19,
for "768552" rea 7 line 6'7 for "100" d 768,852 column read 150 Signed and sealed this 13th day of November 1962.
SEAL) Attest:
Commissioner of Patents

Claims (1)

1. A SOLID MEDICINAL DOSAGE FROM COATING COMPOSITION FOR APPLYING AN EVEN AND UNIFORM FILM COATING WHICH DOES NOT APPRECIABLY LENGTHEN IN DISINTEGRATION TIME ON AGEING COMPRISING A HYDRO-ALCOHOLIC SOLUTION OF A WATER SOLUBLE CELLULOSE DERIVATIVE SELECTED FROM THE GROUP CONSISTING OF METHYLCELLULOSE, HYDROXYETHYL CELLULOSE AND SODIUM CARBOXYMETHYLCELLULOSE AND SUSPENDED SHELLAC.
US90223A 1958-10-22 1961-02-20 Tablets coated with carboxymethylcellulose shellac composition Expired - Lifetime US3043747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US90223A US3043747A (en) 1958-10-22 1961-02-20 Tablets coated with carboxymethylcellulose shellac composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76885258A 1958-10-22 1958-10-22
US76885558A 1958-10-22 1958-10-22
US76885458A 1958-10-22 1958-10-22
US90223A US3043747A (en) 1958-10-22 1961-02-20 Tablets coated with carboxymethylcellulose shellac composition

Publications (1)

Publication Number Publication Date
US3043747A true US3043747A (en) 1962-07-10

Family

ID=27492380

Family Applications (1)

Application Number Title Priority Date Filing Date
US90223A Expired - Lifetime US3043747A (en) 1958-10-22 1961-02-20 Tablets coated with carboxymethylcellulose shellac composition

Country Status (1)

Country Link
US (1) US3043747A (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3132075A (en) * 1960-10-17 1964-05-05 Upjohn Co Solid medicinal dosage forms coated with hydroxyethylcellulose and hydrolyzed styrene-maleic anhydride copolymer
US3244596A (en) * 1962-10-18 1966-04-05 Univ Iowa College Of Pharmacy Coated medicinal agents and coating compositions therefor
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3297535A (en) * 1963-02-28 1967-01-10 Hoffmann La Roche Shellac tablet coating compositions and methods of preparation
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
US3395202A (en) * 1963-06-14 1968-07-30 American Cyanamid Co Pigment composition for marking gelating capsules
US3406031A (en) * 1964-08-27 1968-10-15 Geigy Chem Corp Pharmaceutical dosage unit form coating process
US3427182A (en) * 1965-05-12 1969-02-11 American Cyanamid Co Pigment sealing coats
US3455714A (en) * 1964-09-01 1969-07-15 Hercules Inc Cellulose derivatives of improved dispersibility and process
US3475187A (en) * 1967-06-13 1969-10-28 Rex Lab Inc Edible indelible ink for pharmaceutical pellets
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3988160A (en) * 1974-12-24 1976-10-26 Trexel James J Water-based flemishing composition
US4001390A (en) * 1974-04-04 1977-01-04 Shin-Etsu Chemical Co., Ltd. Method of coating pharmaceutical solid dosage forms
US4050943A (en) * 1973-01-08 1977-09-27 Sondhe Ratanjit S Treatment material and method for exposed aggregate concrete casting
US4421738A (en) * 1979-07-31 1983-12-20 Eisai Co., Ltd. Sugar-coated tablet containing fat-soluble pharmaceutical material
US4661359A (en) * 1985-06-03 1987-04-28 General Mills, Inc. Compositions and methods for preparing an edible film of lower water vapor permeability
US4710228A (en) * 1985-10-16 1987-12-01 General Mills, Inc. Edible coating composition and method of preparation
US4874618A (en) * 1985-12-27 1989-10-17 General Mills, Inc. Package containing a moisture resistant edible internal barrier
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4980173A (en) * 1980-03-20 1990-12-25 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5480479A (en) * 1990-12-20 1996-01-02 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
KR101074496B1 (en) * 2008-06-05 2011-10-17 풍림무약주식회사 Enteric coated composition and preparation method thereof
WO2017142910A1 (en) * 2016-02-16 2017-08-24 Siga Technologies, Inc. St-246 ( tecovirimat monohydrate) suspension formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3132075A (en) * 1960-10-17 1964-05-05 Upjohn Co Solid medicinal dosage forms coated with hydroxyethylcellulose and hydrolyzed styrene-maleic anhydride copolymer
US3244596A (en) * 1962-10-18 1966-04-05 Univ Iowa College Of Pharmacy Coated medicinal agents and coating compositions therefor
US3297535A (en) * 1963-02-28 1967-01-10 Hoffmann La Roche Shellac tablet coating compositions and methods of preparation
US3395202A (en) * 1963-06-14 1968-07-30 American Cyanamid Co Pigment composition for marking gelating capsules
US3406031A (en) * 1964-08-27 1968-10-15 Geigy Chem Corp Pharmaceutical dosage unit form coating process
US3455714A (en) * 1964-09-01 1969-07-15 Hercules Inc Cellulose derivatives of improved dispersibility and process
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3427182A (en) * 1965-05-12 1969-02-11 American Cyanamid Co Pigment sealing coats
US3365365A (en) * 1965-08-09 1968-01-23 Hoffmann La Roche Repeat action pharmaceutical compositions in the form of discrete beadlets
US3475187A (en) * 1967-06-13 1969-10-28 Rex Lab Inc Edible indelible ink for pharmaceutical pellets
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US4050943A (en) * 1973-01-08 1977-09-27 Sondhe Ratanjit S Treatment material and method for exposed aggregate concrete casting
US4001390A (en) * 1974-04-04 1977-01-04 Shin-Etsu Chemical Co., Ltd. Method of coating pharmaceutical solid dosage forms
US3988160A (en) * 1974-12-24 1976-10-26 Trexel James J Water-based flemishing composition
US4421738A (en) * 1979-07-31 1983-12-20 Eisai Co., Ltd. Sugar-coated tablet containing fat-soluble pharmaceutical material
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4980173A (en) * 1980-03-20 1990-12-25 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US5013727A (en) * 1980-03-20 1991-05-07 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4661359A (en) * 1985-06-03 1987-04-28 General Mills, Inc. Compositions and methods for preparing an edible film of lower water vapor permeability
US4710228A (en) * 1985-10-16 1987-12-01 General Mills, Inc. Edible coating composition and method of preparation
US4874618A (en) * 1985-12-27 1989-10-17 General Mills, Inc. Package containing a moisture resistant edible internal barrier
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5480479A (en) * 1990-12-20 1996-01-02 Warner-Jenkinson Company, Inc. Wet powder film-forming compositions
KR101074496B1 (en) * 2008-06-05 2011-10-17 풍림무약주식회사 Enteric coated composition and preparation method thereof
WO2017142910A1 (en) * 2016-02-16 2017-08-24 Siga Technologies, Inc. St-246 ( tecovirimat monohydrate) suspension formulations
CN108430469A (en) * 2016-02-16 2018-08-21 西加技术公司 ST-246 (Te Kaoweirui monohydrates) mixed suspension preparation
US11433051B2 (en) 2016-02-16 2022-09-06 Siga Technologies, Inc. ST-246 (tecovirimat monohydrate) suspension formulations
US11779566B2 (en) 2016-02-16 2023-10-10 Siga Technologies, Inc. ST-246 (tecovirimat monohydrate) suspension formulations

Similar Documents

Publication Publication Date Title
US3043747A (en) Tablets coated with carboxymethylcellulose shellac composition
US2881085A (en) Thin film coating for tablets and the like
US3539380A (en) Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US4802924A (en) Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US3256153A (en) Method of stabilizing wax-fat coating materials and product thereof
AU658141B2 (en) Film-forming product intended for coating solid forms
AU658565B2 (en) Aqueous maltodextrin and cellulosic polymer film coatings
US5006362A (en) Branding pharmaceutical dosage forms, food and confectionery products with aqueous ingestible inks
US3835221A (en) Orally administrable drug dosage form having delayed action
EP0322137B1 (en) Spray dried ibuprofen
TW457101B (en) Film coatings and film coating compositions based on dextrin
EP1315477B1 (en) Dry powder film-coating composition and methods of manufacturing
US3751277A (en) Tablet coating process and composition
US3097144A (en) Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol
JP2002512601A (en) Dextrin based film coatings and film coating compositions
JP2005519853A (en) Use pigments such as titanium dioxide for the purpose of obtaining special optical effects on oral drugs or foods
CH689249A5 (en) pharmaceutical compositions of chewing gum base and process for their preparation.
US3256111A (en) Method for coating tablets
AU2002352226A1 (en) Use of pigment such as E.G. titanium dioxide for obtaining a special optical effect on oral medicament or food
US2954323A (en) Thin film coating for tablets and the like
JPH02288821A (en) Particle and medicine preparation coated with film containing agonist
US3275518A (en) Tablet coating
US3149039A (en) Thin film coating for tablets and the like and method of coating
US3149040A (en) Thin film coating for tablets and the like and method of coating
US3149041A (en) Thin film coating for tablets and the like and method of coating